Xponential Fitness, Inc.
XPOF
$7.37
-$0.66-8.22%
| Weiss Ratings | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D | |||
| Rating Factors | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.06 | |||
| Price History | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.68% | |||
| 30-Day Total Return | -52.81% | |||
| 60-Day Total Return | -48.25% | |||
| 90-Day Total Return | -48.50% | |||
| Year to Date Total Return | -46.95% | |||
| 1-Year Total Return | -49.56% | |||
| 2-Year Total Return | -76.23% | |||
| 3-Year Total Return | -68.68% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -57.63% | |||
| 52-Week Low % Change | 11.30% | |||
| Price | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $18.95 | |||
| 52-Week Low Price | $7.22 | |||
| 52-Week Low Price (Date) | Mar 14, 2025 | |||
| 52-Week High Price (Date) | Jul 18, 2024 | |||
| Valuation | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 270.97M | |||
| Enterprise Value | 656.49M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.25 | |||
| Earnings Per Share Growth | 4.85% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.82 | |||
| Price/Book (Q) | -1.25 | |||
| Enterprise Value/Revenue (TTM) | 2.05 | |||
| Price | $7.40 | |||
| Enterprise Value/EBITDA (TTM) | 8.13 | |||
| Enterprise Value/EBIT | 10.41 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 32.88M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -15.88% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 949 346 3000 | |||
| Address | 17877 Von Karman Avenue Irvine, CA 92614 | |||
| Website | www.xponential.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 19.67% | |||
| Profit Margin | -21.12% | |||
| Management Effectiveness | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.45% | |||
| Return on Equity | -- | |||
| Income Statement | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 320.35M | |||
| Total Revenue (TTM) | 320.35M | |||
| Revenue Per Share | $9.74 | |||
| Gross Profit (TTM) | 212.39M | |||
| EBITDA (TTM) | 80.75M | |||
| EBIT (TTM) | 63.04M | |||
| Net Income (TTM) | -67.66M | |||
| Net Income Avl. to Common (TTM) | -71.43M | |||
| Total Revenue Growth (Q YOY) | -6.32% | |||
| Earnings Growth (Q YOY) | -354.24% | |||
| EPS Diluted (TTM) | -2.25 | |||
| EPS Diluted Growth (Q YOY) | -284.95% | |||
| Balance Sheet | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 16.68M | |||
| Cash Per Share (Q) | $0.51 | |||
| Total Current Assets (Q) | 84.15M | |||
| Total Preferred Equity (Q) | 116.81 | |||
| Total Equity (Q) | -194.01M | |||
| Current Ratio (Q) | 0.780 | |||
| Book Value Per Share (Q) | -$6.43 | |||
| Total Assets (Q) | 403.40M | |||
| Total Current Liabilities (Q) | 107.89M | |||
| Total Debt (Q) | 379.62M | |||
| Total Liabilities (Q) | 597.40M | |||
| Total Common Equity (Q) | -216.57M | |||
| Cash Flow | XPOF - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -14.15M | |||
| Cash from Financing (TTM) | -1.88M | |||
| Net Change in Cash (TTM) | -4.36M | |||
| Levered Free Cash Flow (TTM) | 62.29M | |||
| Cash from Operations (TTM) | 11.68M | |||
